<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Immunometabolic Gatekeeping: Reconciling Peto's & the T-cell Infiltration Prognostic Paradox - Health AI Hub</title>
    <meta name="description" content="This paper introduces an "immunometabolic gatekeeping" framework, positing that the intrinsic metabolic intensity and waste-handling capacity of healthy tissues">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Immunometabolic Gatekeeping: Reconciling Peto's & the T-cell Infiltration Prognostic Paradox</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.20883v1" target="_blank">2511.20883v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-25
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Naomi Iris van den Berg, Matou≈° Elphick, Kevin Mulder, Omar Bouricha, Omid Sadeghi-Alavijeh, Xiao Fu, Samra Turajlic
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.TO
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.20883v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.20883v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces an "immunometabolic gatekeeping" framework, positing that the intrinsic metabolic intensity and waste-handling capacity of healthy tissues fundamentally influence anti-tumor immunity. It suggests that metabolically strenuous tissues can foster immune-exhausting niches even before malignant transformation, thus reconciling paradoxes like high T-cell infiltration with poor prognosis.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research offers a paradigm shift in understanding cancer etiology by emphasizing host tissue metabolism, which could lead to novel strategies for identifying high-risk individuals and developing metabolic-immune combination therapies for prevention and treatment.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The abstract does not describe the use or development of AI. While the identification of 'high-risk patients' could potentially leverage AI/ML techniques in future applications, the paper itself does not specify this.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Classical cancer models often underemphasize the role of the host tissue's metabolic environment in shaping tumor development and immune efficacy.</li>
                    
                    <li>The proposed "immunometabolic gatekeeping" framework identifies tissue-intrinsic metabolic intensity and waste-handling capacity as upstream determinants of anti-tumor immunity.</li>
                    
                    <li>Human cancers show that tumors arising in high-metabolism tissues (e.g., kidney, brain, eye) often exhibit high T-cell infiltration but are paradoxically associated with poor prognosis.</li>
                    
                    <li>Cross-species comparisons support this: large mammals with lower mass-specific metabolic rates show lower cancer incidence (Peto's paradox), while long-lived small mammals resist cancer via metabolic adaptations like suppressed glycolysis.</li>
                    
                    <li>The framework suggests that tissues with high metabolic rates and inefficient waste clearance create chronic immune-exhausting microenvironments prior to tumor formation.</li>
                    
                    <li>This unifying theory reconciles multiple paradoxes in cancer biology, including Peto's paradox, the non-prognosticity of T-cell infiltration, tissue tropisms, and sex-based inequalities in cancer incidence/outcome.</li>
                    
                    <li>The work advocates a shift in focus from solely tumor-intrinsic mutations to host-tissue metabolism as a critical factor in cancer vulnerability and immune failure.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employs an integrative synthesis approach, drawing insights from human single-cell expression data analysis and extensive cross-species comparisons to develop and substantiate the immunometabolic gatekeeping framework.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The primary finding is the establishment of the "immunometabolic gatekeeping" framework, which posits that tissues with high metabolic rates and poor waste clearance are predisposed to creating immune-exhausting niches, thereby undermining effective anti-tumor immunity. This framework successfully unifies explanations for previously disparate observations in cancer biology, including Peto's paradox and the T-cell infiltration prognostic paradox.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The clinical impact includes the potential for improved risk stratification in cancer patients based on host tissue metabolic profiles. It also paves the way for designing innovative metabolic-immune combination strategies that target the systemic or tissue-specific metabolic environment, potentially leading to more effective cancer prevention and treatment outcomes.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract presents a conceptual framework derived from integrative synthesis, implying that while strongly supported by existing data, the mechanistic details and direct causal links would require further experimental validation in preclinical models and human clinical studies.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future research should focus on validating the specific molecular and cellular mechanisms of immunometabolic gatekeeping, developing biomarkers to identify high-risk metabolic tissue environments, and designing and evaluating metabolic-immune combination strategies for cancer prevention and treatment.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Immunology</span>
                    
                    <span class="tag">Metabolic Medicine</span>
                    
                    <span class="tag">Cancer Prevention</span>
                    
                    <span class="tag">Personalized Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Immunometabolism</span>
                    
                    <span class="tag tag-keyword">Peto's Paradox</span>
                    
                    <span class="tag tag-keyword">T-cell infiltration</span>
                    
                    <span class="tag tag-keyword">Cancer prognosis</span>
                    
                    <span class="tag tag-keyword">Metabolic gatekeeping</span>
                    
                    <span class="tag tag-keyword">Tissue metabolism</span>
                    
                    <span class="tag tag-keyword">Immune exhaustion</span>
                    
                    <span class="tag tag-keyword">Cancer prevention</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Classical models of cancer focus on tumour-intrinsic genetic aberrations and immune dynamics and often overlook how the metabolic environment of healthy tissues shapes tumour development and immune efficacy. Here, we propose that tissue-intrinsic metabolic intensity and waste-handling capacity act as an upstream gatekeeper of anti-tumour immunity, determining whether immune infiltration translates into effective immune function and safeguards the tissue from tumourigenesis. Across human cancers, tumours arising in high-metabolism tissues - like kidney, brain, and eye - tend to show high T cell infiltration but poor prognosis, suggesting pre-existing metabolic environments prior to malignant transformation may undermine immune function. This pattern is mirrored across species: large mammals with lower mass-specific metabolic rates (e.g., elephants, whales) accumulate fewer metabolic byproducts and show lower cancer incidence (Peto's paradox), while long-lived small mammals like bats and naked mole-rats resist tumourigenesis via suppressed glycolysis or altered hypoxia responses leading to lower metabolic rates and/or byproduct accumulation. Through integrative synthesis spanning human single-cell expression data and cross-species comparisons, we outline a framework of 'immunometabolic gatekeeping', where tissues with high metabolic rate and poor waste clearance foster immune-exhausting niches even before transformation. This unifying framework reconciles multiple paradoxes in cancer biology: Peto's paradox, T cell infiltration non-prognosticity, tissue tropisms, and sex-based inequalities, and suggests new principles for identifying high-risk patients and metabolic-immune combination strategies for prevention and treatment. By shifting focus from tumour-intrinsic mutations to host-tissue metabolism, this work offers a novel, integrative lens on cancer vulnerability and immune failure.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>31 pages (including Supplementary materials), 4 main figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>